MyFinsight
Home
Blog
About
Contact
Download
Download image
Comprehensive loss
-$47,314,379
(-26.62%↓ Y/Y)
Net loss
-$46,895,936
(-24.59%↓ Y/Y)
Total other
comprehensive income (loss)
-$418,443
(-253.98%↓ Y/Y)
Income tax provision
(benefit)
-$1,615,978
(-2916.86%↓ Y/Y)
Gain on
remeasurement of acquisition...
$805,863
(12.73%↑ Y/Y)
Realized gain on
investments
$683,365
(-21.52%↓ Y/Y)
Interest income, net
$292,932
(-73.17%↓ Y/Y)
Product
$418,205
Grant
$204,284
Loss before income
taxes
-$48,511,914
(-29.08%↓ Y/Y)
Change in net
unrealized gains (losses)...
-$418,443
(-253.98%↓ Y/Y)
Total other income,
net
$1,653,438
(-33.85%↓ Y/Y)
Total revenue
$622,489
(-84.10%↓ Y/Y)
Gain (loss) on
disposition of assets
-$82,421
(-1094.10%↓ Y/Y)
Loss on equity method
investment in joint...
-$46,301
(75.12%↑ Y/Y)
Loss from operations
-$50,165,352
(-25.16%↓ Y/Y)
Gross profit
$400,112
(-86.28%↓ Y/Y)
Cost of revenue
$222,377
(-77.74%↓ Y/Y)
Total operating
expenses
$50,565,464
(17.60%↑ Y/Y)
Research and development
$19,137,242
(-8.78%↓ Y/Y)
Impairment charges
$18,882,000
General and
administrative
$9,058,283
(-43.94%↓ Y/Y)
Sales and marketing
$2,381,131
(-46.89%↓ Y/Y)
Depreciation and
amortization
$1,106,808
(-19.64%↓ Y/Y)
Back
Back
Income Statement
source: myfinsight.com
Co-Diagnostics, Inc. (CODX)
Co-Diagnostics, Inc. (CODX)